shRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung Metastases In Vitro and In Vivo .

MLA

Zapata-Benavides, Pablo, et al. “ShRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung Metastases In Vitro and In Vivo .” In Vivo (Athens, Greece), vol. 33, no. 3, May 2019, pp. 777–85. EBSCOhost, https://doi.org/10.21873/invivo.11539.

APA

Zapata-Benavides, P., Thompson-Armendariz, F. G., Arellano-Rodríguez, M., Franco-Molina, M. A., Mendoza-Gamboa, E., Saavedra-Alonso, S., Zacarias-Hernández, J. L., Trejo-Avila, L. M., & Rodríguez-Padilla, C. (2019). shRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung Metastases In Vitro and In Vivo . In Vivo (Athens, Greece), 33(3), 777–785. https://doi.org/10.21873/invivo.11539

Chicago

Zapata-Benavides, Pablo, Fernanda Guadalupe Thompson-Armendariz, Mariela Arellano-Rodríguez, Moisés Armides Franco-Molina, Edgar Mendoza-Gamboa, Santiago Saavedra-Alonso, José Luis Zacarias-Hernández, Laura María Trejo-Avila, and Cristina Rodríguez-Padilla. 2019. “ShRNA-WT1 Potentiates Anticancer Effects of Gemcitabine and Cisplatin Against B16F10 Lung Metastases In Vitro and In Vivo .” In Vivo (Athens, Greece) 33 (3): 777–85. doi:10.21873/invivo.11539.